Table 1. Main studies comparing sentinel node mapping vs. lymphadenectomy in high-risk endometrial cancer endometrial cancer.

Author	Patients	Study arms	Oncologic outcomes
Zammarrelli et al. [6]	199 uterine carcinosarcoma	99 SNM	3-yrs PFS: 62.9%; OS: 72.1%
		100 LND	3-yrs PFS: 52.3%; OS: 71.6%
Schlappe et al. [36]	176 deep invasive endometrioid EC patients	82 SNM	3-yrs PFS: 78.7%; OS: 91.8%
		94 LND	3-yrs PFS: 77.7%; OS: 77.6%
Schlappe et al. [29]	214 serous and clear cell EC patients	118 SNM	3-yrs PFS: 69%; OS: 88%
		96 LND	3-yrs PFS: 80%; OS: 77%
Bogani et al. [30]	100 high-risk EC patients	50 SNM	PFS: 84%; OS: 88% at 16 mo
		50 SNM plus LND	PFS: 88%; OS: 88% at 18 mo
Holtzman et al. [37]	189 high-risk EC patients	46 SNM	3-yrs PFS: 71.1%; OS: 81.1%
		143 LND	3-yrs PFS: 71.3%; OS: 95.1%

SNM, sentinel node mapping; LND, lymphadenectomy; PFS, progression-free survival; OS, overall survival.